Search research articles
Contact Us
Filters
Showing results (111-120 of 170) with videos related to
Page
of 17
Sort By:
Haematologica
|
April 4, 2024
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma
Umair Munawar, Johanna Theuersbacher, Maximilian J Steinhardt, et al.
Communications Biology
|
June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Hemasphere
|
June 9, 2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma
Gala Vega, Daniel Morillo, Christine Riedhammer, et al.
Blood
|
April 23, 2017
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma
Leo Rasche, Edgardo Angtuaco, James E McDonald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
Ingo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, et al.
Leukemia
|
April 15, 2018
Kinase domain activation through gene rearrangement in multiple myeloma
Gareth J Morgan, Jie He, Ruslana Tytarenko, et al.
British Journal of Haematology
|
October 11, 2014
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease
Klaus M Kortüm, Christian Langer, Jorge Monge, et al.
Haematologica
|
February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex
Xiang Zhou, Andrej Besse, Jessica Peter, et al.
Cancer
|
July 9, 2025
Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study
Carolina Schinke, Cyrille Touzeau, Albert Oriol, et al.
Blood
|
June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
Alexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 170) with videos related to
Sort By:
Page
of 17
Haematologica
|
April 4, 2024
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma
Umair Munawar, Johanna Theuersbacher, Maximilian J Steinhardt, et al.
Communications Biology
|
June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Hemasphere
|
June 9, 2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma
Gala Vega, Daniel Morillo, Christine Riedhammer, et al.
Blood
|
April 23, 2017
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma
Leo Rasche, Edgardo Angtuaco, James E McDonald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
Ingo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, et al.
Leukemia
|
April 15, 2018
Kinase domain activation through gene rearrangement in multiple myeloma
Gareth J Morgan, Jie He, Ruslana Tytarenko, et al.
British Journal of Haematology
|
October 11, 2014
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease
Klaus M Kortüm, Christian Langer, Jorge Monge, et al.
Haematologica
|
February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex
Xiang Zhou, Andrej Besse, Jessica Peter, et al.
Cancer
|
July 9, 2025
Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study
Carolina Schinke, Cyrille Touzeau, Albert Oriol, et al.
Blood
|
June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
Alexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.
Page
of 17